2
SEC. 2. MEDICARE PART B PRESCRIPTION DRUG INFLATION REBATE BY MANUFACTURERS.
(a) In General.—Section 1834 of the Social Security Act (42 U.S.C. 1395m) is amended by adding at the end the following new subsection:
“(x) Rebate by Manufacturers for Single Source Drugs With Prices Increasing Faster Than Inflation.—
“(1) Requirements.—
“(A) Secretarial Provision of Information.—Not later than 6 months after the end of each calendar quarter beginning on or after July 1, 2021, the Secretary shall, for each part B rebatable drug, report to each manufacturer of such part B rebatable drug the following for such calendar quarter:
“(i) Information on the total number of billing units described in subparagraph (A)(i) of paragraph (3) with respect to such drug and calendar quarter.
“(ii) Information on the amount (if any) of the excess average sales price increase described in subparagraph (A)(ii) of such paragraph for such drug and calendar quarter.
·HR 4663 TH
